Screening for cognitive and affective dysfunction in patients suspected of mild cognitive impairment

Prigatano, George P.; Montreuil, Michèle; Chapple, Kristina; Tonini, Audrey; Toron, Justine; Paquet, Claire; Dumurgier, Julien; Hugon, Jacques; Truelle, Jean-Luc

doi:10.1002/gps.4082

Cited by 7 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The BNIS is easy and fast to administer (13.8 minutes for neurological and psychiatric populations and 11.8 minutes for healthy participants, Prigatano et al, 2013). Furthermore, several studies (Boosman, Visser-Meily, Post, Duits, and van Heugten, 2013; Prigatano et al, 2014; Redfors et al, 2014) have shown that the BNIS is more sensitive than the MMSE in various neurological diseases (brain injury, stroke) that share characteristics with MS (e.g., slowing of processing speed). This screening tool might be of value in MS for the detection of both cognitive and behavioural disturbances and in helping to select patients for testing on the basis of a more complete cognitive and affective battery.…”

Section: Discussionmentioning

confidence: 99%

Facial Emotion Recognition and Faux Pas Interpretation in Multiple Sclerosis

et al. 2015

View full text Add to dashboard Cite

Multiple sclerosis (MS) is an inflammatory disease of the central nervous system leading to physical and cognitive disability. The impact of the disease on social cognition has only come to light quite recently. The aim of this study was to evaluate the social cognition abilities of MS patients and their links with characteristics of the disease, such as physical disability, cognitive impairment and disease duration. The performances of a group of 64 MS patients were compared with that of 30 matched healthy individuals in facial emotion recognition and Faux Pas tasks as well as on a battery of standardized neuropsychological tests. The MS patients performed worse than the control group in the recognition of the expressions of fear and anger and in the interpretation of faux pas. The impairment in social cognition increased with overall disease course. Executive impairment did not correlate with the performance in the social cognition tests. Our results show that emotional impairment is observed at early stages of the disease in the absence of cognitive dysfunction, even if social cognition abilities worsen with the progression of MS. These data highlight the need to attempt to identify these impairments in clinical practice.

show abstract

Section: Discussionmentioning

confidence: 99%

Facial Emotion Recognition and Faux Pas Interpretation in Multiple Sclerosis

et al. 2015

View full text Add to dashboard Cite

show abstract

“…MCI is the transitional stage of cognitive function between normal aging and dementia. Although the cognitive function of people with MCI has not reached dementia, their core symptom, impaired memory, and complicated executive functions are significantly poorer than those of people with normal cognitive functions (Prigatano et al, 2014). Compared with people with normal cognitive functioning, every year approximately 10–15% of people with MCI will progress to dementia (Albert et al, 2011), and the chance of people with MCI progressing to dementia within one year is 10 times higher than those with normal cognitive functioning (Lopez‐Anton et al, 2015).…”

Section: Introductionmentioning

confidence: 99%

Effects of the biopsychosocial functional activity program on cognitive function for community older adults with mild cognitive impairment: A cluster‐randomized controlled trial

Lin

Wang

Chang

et al. 2020

Nursing & Health Sciences

View full text Add to dashboard Cite

Early preventive interventions may delay the onset of dementia for people with mild cognitive impairment. This study was designed to examine the effects of the biopsychosocial functional activity program on the cognitive function of community middle to older adults with mild cognitive impairment. A cluster-randomized controlled trial was conducted. The experimental group received a 12-month biopsychosocial functional activity program intervention that contained two phases. The first phase was a 6-week teaching program followed by a second-phase home follow-up phase. The measurement was carried out at baseline, 6 months and 12 months after the biopsychosocial functional activity program. The measurement tool was the Chinese version of the Saint Louis University Mental Status Examination. The Generalized Estimating Equations statistical approach was used to analyze the data. The experimental group showed significant short-term and continuous improvement in overall cognitive function in the immediate-and short-term memory domain while the domain of attention and executive function showed improvement on the 12-month measurement compared to the control group. Yet, there was no significant improvement overall and in the three domains of cognitive function for the control group. The findings may become references for advancing the dementia prevention program for communities as well as the national policies for dementia prevention programs.

show abstract

Barrow Neuropsychological Screen

Prigatano

2017

Encyclopedia of Clinical Neuropsychology

View full text Add to dashboard Cite

Screening for cognitive and affective dysfunction in patients suspected of mild cognitive impairment

Abstract: This sample of MCI patients demonstrated disturbances not only in memory but also in self-awareness and affect expression and perception on the BNIS. These dimensions should be included in the neuropsychological assessment of patients suspected of MCI.

Cited by 7 publications

References 22 publications

Facial Emotion Recognition and Faux Pas Interpretation in Multiple Sclerosis

Facial Emotion Recognition and Faux Pas Interpretation in Multiple Sclerosis

Effects of the biopsychosocial functional activity program on cognitive function for community older adults with mild cognitive impairment: A cluster‐randomized controlled trial

Barrow Neuropsychological Screen

Contact Info

Product

Resources

About